RxDoctor Payments Data
★ My doctorsLook up a doctor →

Nadine Abi-Jaoudeh, MD

Vascular & Interventional Radiology · Orange, CANPI 1235337627

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $66,384 of the $104,683 with a category attached, or 63.4%. It is spread thinly across 24 manufacturers, the largest accounting for just 21.7%. Among vascular & interventional radiology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$104,683in general payments, 2019–2025

Across 186 payments — averaging $562.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$23K
  • Instylla, Inc.$17K
  • Sirtex Medical Inc$10K
  • AstraZeneca$10K
  • Eisai Inc.$8K
  • Genentech USA, Inc.$7K
  • plus $30K from 18 others
$1,162,838in research payments, 2019–2025

Across 68 payments — averaging $17,101 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$510K
  • Instylla, Inc.$164K
  • ABK Biomedical USA, Inc.$148K
  • Guerbet LLC$144K
  • Blackswan Vascular, Inc.$60K
  • Sirtex Medical Inc$34K
  • plus $103K from 5 others

What the payments were for

  • Consulting fees$66,38463%
  • Speaking & faculty fees$18,85018%
  • Travel & lodging$7,0487%
  • Food & beverage$12,40012%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific43$22,672
Instylla, Inc.13$16,554
Sirtex Medical Inc13$10,497
AstraZeneca12$10,317
Eisai Inc.5$7,866
Genentech USA, Inc.8$7,052
Medtronic21$4,415
Medical Device Business Services, Inc.2$4,095
Angiodynamics, Inc.4$3,231
Guerbet LLC7$3,100
Siemens Medical Solutions USA, Inc.5$2,750
Johnson & Johnson5$2,525
Terumo Medical Corporation11$2,017
Genentech, Inc.1$1,822
Histosonics, Inc.4$1,316
Astrazeneca UK Limited9$1,138
ABK Biomedical USA, Inc.11$1,081
Pfizer1$1,000
Inari Medical, Inc.2$396
Trisalus Life Sciences, Inc.3$385
Varian Medical Systems, Inc.2$185
Penumbra, Inc.1$172
Abbott2$48
Bard Access Systems, Inc.1$47

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$104,683 in reported general payments places this provider in the 90th percentile of 504 vascular & interventional radiology providers in California.

See all vascular & interventional radiology providers in California →

Medicare billing

Part B allowed, 2024
$77,333
Medicare patients
103
Services billed
622

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Orange

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →